This request seems a bit unusual, so we need to confirm that you’re human. Please press and hold the button until it turns completely green. Thank you for your cooperation!
Press and hold the button
If you believe this is an error, please contact our support team.
192.64.82.12 : 792fabb9-921c-4d09-8930-9679f985
A multi-national, multi-institutional study led by Weill Cornell Medicine investigators found little natural resistance to a new HIV therapy called lenacapavir in a population of patients in Uganda. The study,
The detection of cancer-associated micro-ribonucleic acids (miRNAs) in urine through a combination of nanowire-based miRNA extraction and machine learning (ML) analysis by researchers from Institute of Science Tokyo (Science Tokyo)
Dominic Hughes Health Correspondent Annabel Rackham Health Reporter Getty Images Health experts are urging anyone having sex with a new or casual partner to use a condom New cases of
